Blood and Lymphatic Cancer: Targets and Therapy
Dove Medical Press
About the journal
Blood and Lymphatic Cancer: Targets and Therapy is an open-access journal published by Dove Medical Press in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 3,565 USD. Declared review time at DOAJ: 16 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Dove Medical Press
- ISSN
- 1179-9889
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 3,565 USD
- Articles in DOAJ
- 142
- Declared review time
- 16 weeks
- Declared peer-review model
- peer_review
Index listings
- DOAJ · 2012-11-26
- Indexing
- DOAJ
- APC
- 3,565 USD
- Declared review time (DOAJ)
- 16 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
142
Most recent article
last month
Average review time (journal-declared via DOAJ)
16weeks
Works in OpenAlex
144
Last recorded publication year
2026
h-index
18
i10-index
39
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2012-11-26
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMC
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSS
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 87%
- ORCID iDs in current deposits
- 68%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- Blood and lymphatic cancer, targets and therapy
- Source type
- journal
- NLM unique ID (PubMed)
- 101596730
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Acute Myeloid Leukemia Research
- Acute Myeloid Leukemia Research
- Acute Lymphoblastic Leukemia research
- Acute Lymphoblastic Leukemia research
Show all subjects (50)
- Multiple Myeloma Research and Treatments
- Multiple Myeloma Research and Treatments
- Chronic Myeloid Leukemia Treatments
- Chronic Myeloid Leukemia Treatments
- CAR-T cell therapy research
- CNS Lymphoma Diagnosis and Treatment
- CAR-T cell therapy research
- CNS Lymphoma Diagnosis and Treatment
- Protein Degradation and Inhibitors
- Protein Degradation and Inhibitors
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Viral-associated cancers and disorders
- Viral-associated cancers and disorders
- Hematopoietic Stem Cell Transplantation
- Eosinophilic Disorders and Syndromes
- Hematopoietic Stem Cell Transplantation
- Eosinophilic Disorders and Syndromes
- Childhood Cancer Survivors' Quality of Life
- Ubiquitin and proteasome pathways
- Immune Cell Function and Interaction
- Immunodeficiency and Autoimmune Disorders
- Childhood Cancer Survivors' Quality of Life
- Ubiquitin and proteasome pathways
- Immune Cell Function and Interaction
- Immunodeficiency and Autoimmune Disorders
- Cutaneous lymphoproliferative disorders research
- Cutaneous lymphoproliferative disorders research
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
- Retinoids in leukemia and cellular processes
- Retinoids in leukemia and cellular processes
- T-cell and Retrovirus Studies
- Peptidase Inhibition and Analysis
- Histone Deacetylase Inhibitors Research
- Cancer-related molecular mechanisms research
- Kruppel-like factors research
- T-cell and Retrovirus Studies
- Cancer-related molecular mechanisms research
- Histone Deacetylase Inhibitors Research
- Kruppel-like factors research
- Peptidase Inhibition and Analysis
Keywords (DOAJ)
- lymphoma
- anticancer agents
- haematology
- leukaemia
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ